Mereo BioPharma Group plc

MREO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$48,698$56,125$62,483$69,802
Short-Term Investments$0$0$0$0
Receivables$0$3,747$2,398$3,250
Inventory$0$0$0$0
Other Curr. Assets$3,709$1,549$2,018$1,711
Total Curr. Assets$52,407$61,421$66,899$74,763
Property Plant & Equip (Net)$552$740$869$984
Goodwill$0$0$0$0
Intangibles$643$470$554$643
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$1,195$1,210$1,423$1,627
Other Assets$0$0$0$0
Total Assets$53,602$62,631$68,322$76,390
Liabilities
Payables$879$1,138$2,924$2,440
Short-Term Debt$397$601$747$6,242
Tax Payable$0$485$370$770
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,740$5,333$3,456$4,396
Total Curr. Liab.$6,016$7,557$7,497$13,848
LT Debt$0$0$0$187
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$988$897$744$1,386
Total NC Liab.$988$897$744$1,573
Other Liabilities$0$0$0$0
Cap. Leases$0$601$747$894
Total Liabilities$7,004$8,454$8,241$15,421
Equity
Pref Stock$0$0$0$0
Common Stock$3,134$3,132$3,132$3,059
Retained Earnings-$493,667-$486,643-$472,027-$462,883
AOCI-$10,910-$8,643-$15,290-$18,849
Other Equity$548,041$546,331$544,266$539,642
Total Equity$46,598$54,177$60,081$60,969
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$53,602$62,631$68,322$76,390
Net Debt-$48,301-$55,524-$61,736-$63,373
Mereo BioPharma Group plc (MREO) Financial Statements & Key Stats | AlphaPilot